Single psychedelic dose tested for relief from depression and anxiety
NCT ID NCT06820723
Summary
This study is testing if a single oral dose of a drug related to psilocybin (the psychedelic compound in 'magic mushrooms') can help reduce symptoms of depression and anxiety. It will involve 40 adults with major depressive disorder who haven't gotten enough relief from their current antidepressant. Researchers will use brain scans and questionnaires to see how the drug affects symptoms and brain function.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Ohio State University Department of Psychiatry
Columbus, Ohio, 43210, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.